Trial Information

Summary: Do You Have Crohn's Disease? Have You Received Infliximab (Remicade) Therapy?

Dr. Barry P. Kaufman and Atlantic Gastroenterology Associates are conducting a clinical Research trial to test the safety and effectiveness of an injectable investigational medication in patients with active moderate to severe Crohn's disease who have lost response to or are intolerant to Infliximab (Remicade). Your participation in this study would last for up to 6 weeks with the opportunity to enter another study where you will receive active study medication. While in this study, you will receive physical exams, blood tests and tests for your disease, free of charge.

Subjects who are eligible to participate in this clinical trial include the following:

• Men or women between the ages of 18 and 75.
• Diagnosis of Crohn's disease confirmed by an endoscopy or radiologic evidence.
• Women cannot be pregnant or breastfeeding.
• Subjects must have previously received Infliximab (Remicade) therapy.

For more information,

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: February 25, 2008 at 2:29:08 PM